SCR-LIP-000300 · Claim · machine-readable JSON →
In a cross-sectional comparison of 53 women with lipedema versus 55 with lifestyle-induced overweight/obesity, despite lower BMI the lipedema group showed more favorable metabolic profiles (lower TG, LDL-C, HbA1c, HOMA-IR, uric acid; higher HDL-C; insulin resistance 11.3% vs 34.5%, p=0.01), and PCA identified the fat-distribution component (more peripheral/limb fat vs abdominal, higher PC3) as the strongest predictor of better metabolic markers independent of total body weight.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Metabolic Alterations in Women with Lipedema Compared to Women with Lifestyle-Induced Overweight/Obesity — Jeziorek et al. (2025) ✓ verified — consistent · cross sectional · 2025 · reading confidence: high
“Maior proporção de gordura nas extremidades protege o perfil metabólico independentemente do peso total. Apesar do IMC elevado, mulheres com lipedema apresentam menos alterações metabólicas do que mulheres com sobrepeso/obesidade de origem comportamental.”
The article directly tests whether gynoid/peripheral fat distribution is associated with better metabolic markers, finding via multivariate PCA that greater limb (vs abdominal) fat independently predicts more favorable lipid, glycemic and u
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000010